Hologic Announces Financial Results for Second Quarter of Fiscal 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Hologic (HOLX) Tops Q2 EPS by 47c; Offers FY22 Guidance
April 27, 2022 4:03 PM EDTHologic (NASDAQ: HOLX) reported Q2 EPS of $2.07, $0.47 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.29 billion.
GUIDANCE:
Hologic sees FY2022 EPS of $5.45-$5.65, versus the consensus of $5.15. Hologic sees... More



